$0.532
-0.013[-2.39%]
At close: Apr 25
$0.5447
0.0127[2.39%]
After Hours: 9:29AM EDT
Brainstorm Cell
(NASDAQ:BCLI)Brainstorm Cell Stock (NASDAQ:BCLI), Analyst Ratings, Price Targets, Predictions
Brainstorm Cell Therapeutics Inc has a consensus price target of $0, established from looking at the 2 latest analyst ratings. The last 2 analyst ratings were released from Maxim Group and Maxim Group on September 28, 2023 and March 31, 2023. With an average price target of $5 between Maxim Group and Maxim Group, there's an implied 817.94% upside for Brainstorm Cell Therapeutics Inc from these 2 analyst ratings.
Analyst Firms Making Recommendations1
Maxim Group
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Brainstorm Cell
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 09/28/2023 | BCLI | Buy Now | Brainstorm Cell | $0.54 | — | Maxim Group | Jason McCarthy | — | Downgrade | Buy → Hold | Get Alert |
| 03/31/2023 | BCLI | Buy Now | Brainstorm Cell | $0.54 | 1735.87% | Maxim Group | Jason McCarthy | $5 → $10 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Brainstorm Cell (BCLI)?
The latest price target for Brainstorm Cell (NASDAQ: BCLI) was reported by Maxim Group on September 28, 2023. The analyst firm set a price target for $0.00 expecting BCLI to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Brainstorm Cell (BCLI)?
The latest analyst rating for Brainstorm Cell (NASDAQ: BCLI) was provided by Maxim Group, and Brainstorm Cell downgraded their hold rating.
When was the last upgrade for Brainstorm Cell (BCLI)?
There is no last upgrade for Brainstorm Cell.
When was the last downgrade for Brainstorm Cell (BCLI)?
The last downgrade for Brainstorm Cell Therapeutics Inc happened on September 28, 2023 when Maxim Group changed their price target from N/A to N/A for Brainstorm Cell Therapeutics Inc.
When is the next analyst rating going to be posted or updated for Brainstorm Cell (BCLI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Brainstorm Cell, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Brainstorm Cell was filed on September 28, 2023 so you should expect the next rating to be made available sometime around September 28, 2024.
Is the Analyst Rating Brainstorm Cell (BCLI) correct?
While ratings are subjective and will change, the latest Brainstorm Cell (BCLI) rating was a downgraded with a price target of $0.00 to $0.00. The current price Brainstorm Cell (BCLI) is trading at is $0.53, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.